Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial

Clinical trial NCT06429384 · COMPLETED

Trial details

NCT number: NCT06429384
Sponsor: Beijing Tiantan Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2023-06-04
Primary completion: 2023-11-18
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.